Propionic Acid

Propionic Acid

SCHEMBL4157596

CCC(=O)O.COc1cccc(S(=O)(=O)Nc2ccc3[nH]c(=O)c4[nH]ccc4c3c2)c1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.52
PGR P06401 2/20 0.46
MAPT P10636 3/20 0.45
TP53 P04637 3/20 0.45
LMNA P02545 2/20 0.45
ITK Q08881 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
POLB P06746 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4164331 0.93 MAPT (0.54) BRD4MAPTTP53LMNAPOLB
Propionic Acid SCHEMBL4164250 0.90 BRD4 (0.62) BRD4MAPTTP53LMNAPOLB
Propionic Acid SCHEMBL4158106 0.89 BRD4 (0.60) BRD4
Propionic Acid SCHEMBL4162506 0.88 BRD4 (0.50) BRD4MAPTTP53LMNAALDH1A1
Propionic Acid SCHEMBL4163726 0.88 BRD4 (0.54) BRD4MAPTTP53LMNAPOLB
Propionic Acid SCHEMBL4157723 0.88 BRD4 (0.62) BRD4PGRALDH1A1PKM
Propionic Acid SCHEMBL4160919 0.88 BRD4 (0.49) BRD4PGRMAPTTP53LMNA
Propionic Acid SCHEMBL4157756 0.86 BRD4 (0.63) BRD4LMNASMN1; SMN2ALDH1A1PKM
Propionic Acid SCHEMBL4155591 0.83 BRD4 (0.50) BRD4MAPTTP53LMNAPOLB
Propionic Acid SCHEMBL4163285 0.83 PKM (0.54) BRD4MAPTTP53LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 BRD4 545/4885PGR 1089/4885MAPT 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.